<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Estrogen therapy not beneficial for secondary prevention of coronary heart disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Estrogen therapy not beneficial for secondary prevention of coronary heart disease</h1>
<div class="graphic"><div class="figure"><div class="ttl">Estrogen therapy not beneficial for secondary prevention of coronary heart disease</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Data from the HERS-II trial on the incidence of coronary heart disease events (death or nonfatal myocardial infarction) in 2763 postmenopausal women with a prior history of myocardial infarction or interventional procedure who were treated with combined HRT or placebo. There was no difference between the two groups. The curves are truncated at year 7 when less than half of the cohort remained in follow-up.</div><div class="graphic_footnotes">HERS II: Heart and Estrogen/progestin Replacement Study follow-up; HRT: hormone replacement therapy.</div><div class="graphic_reference">Data from: Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).Â JAMA 2002; 288:49.</div><div id="graphicVersion">Graphic 62591 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
